Scotland will become the first UK nation to routinely offer HIV pre-exposure prophylaxis to all eligible patients after the Scottish Medicines Consortium backed the use of Gilead’s Truvada alongside four other new therapies to be funded by the NHS.
Read More
The Court of Appeal has ruled that NHS England does indeed have the legal power to fund what campaigners refer to as a “game-changing” drug to prevent the transmission of HIV under a strategy called Pre-Exposure Prophylaxis (PrEP).
Read More
Eight medicines have taken a big leap towards being approved in Europe having won the support of the European Medicines Agency’s Committee for Medicinal Products for Human Use.
Read More
The National Institute for Health and Care Excellence has published an evidence summary on the use of Gilead’s Truvada for HIV pre-exposure prophylaxis (PrEP) in adults at high risk of infection.
Read More
